CSIMarket
 


Qhslab Inc   (USAQ)
Other Ticker:  
 

Cumulative Qhslab Inc 's Working Capital Ratio for Trailing Twelve Months Period

USAQ's Working Capital Ratio for Trailing Twelve Months Period and Current Assets, Current Liabilities growth


Select the Comparisons : Select the Ratio:

USAQ Working Capital Ratio for Trailing Twelve Months Period

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities Growth 23.05 % 52.61 % 74.86 % 95.06 % 88.4 %
Y / Y Current Assets Growth -60.08 % -14.63 % -47.98 % -35.94 % -38.45 %
Working Capital Ratio for Trailing Twelve Months Period 0.12 0.16 0.19 0.25 0.32
Total Ranking # 3805 # 3984 # 4153 # 4739 # 4460
Seq. Current Liabilities Growth -1.3 % 14.05 % 6.09 % 3.03 % 22.41 %
Seq. Current Assets Growth -29.12 % 21.02 % -27.74 % -35.58 % 51.55 %


Working Capital Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2023
On the trailing twelve months basis Due to decrease in Current Liabilities in the III. Quarter to $2 millions, average cumulative Working Capital Ratio for Trailing Twelve Months Period decreased to 0.12 below Qhslab Inc average Working Capital Ratio for Trailing Twelve Months Period.
Working Capital Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Medical Equipment & Supplies industry 219 other companies have achieved higher Working Capital Ratio for Trailing Twelve Months Period than Qhslab Inc . While overall ranking remained unchanged compare to previous quarter at no. .

What is Working Capital Ratio?
More about USAQ
Working Capital Ratio USAQ in the most recent quarter
Working Capital Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 220
Sector # 1016
S&P 500 # 3838


Working Capital Ratio for Trailing Twelve Months Period Statistics
High Average Low
1.01 0.37 0.01
(Jun 30 2021)   (Jun 30 2019)




Companies with similar average Working Capital Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2023, within Medical Equipment & Supplies Industry Working Capital Ratio for Trailing Twelve Months Period
Yubo International Biotech Limited  0.31 
Invo Bioscience Inc   0.30 
Arch Therapeutics Inc   0.29 
G Medical Innovations Holdings Ltd   0.22 
Non Invasive Monitoring Systems Inc  0.21 
Nu med Plus Inc   0.21 
Aurora Technology Acquisition Corp   0.18 
Todos Medical Ltd   0.18 
Therapeutic Solutions International Inc   0.16 
Vycor Medical Inc   0.16 
Altair International Corp   0.16 
Qhslab Inc   0.15 
Sanuwave Health Inc   0.11 
Neuraxis Inc   0.10 
Marizyme Inc   0.09 
Legacy Ventures International Inc  0.09 
Odyssey Health Inc   0.09 
Longview Acquisition Corp Ii  0.07 
United Health Products Inc   0.07 
Sensasure Technologies Inc   0.07 
Qt Imaging Holdings Inc   0.05 
Blueriver Acquisition Corp   0.04 
Sigyn Therapeutics Inc   0.04 
Prolung Inc   0.04 
Achari Ventures Holdings Corp I  0.04 
American International Holdings Corp   0.04 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com